EWTX
Edgewise Therapeutics Inc

577
Mkt Cap
$2.36B
Volume
21.00
52W High
$32.61
52W Low
$10.60
PE Ratio
-13.41
EWTX Fundamentals
Price
$21.15
Prev Close
$22.31
Open
$22.31
50D MA
$19.94
Beta
1.36
Avg. Volume
1.3M
EPS (Annual)
-$1.45
P/B
4.00
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Edgewise Therapeutics (NASDAQ:EWTX) Trading 4% Higher - Still a Buy?
Edgewise Therapeutics (NASDAQ:EWTX) Trading 4% Higher - Should You Buy...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Braidwell LP Raises Position in Edgewise Therapeutics, Inc. $EWTX
Braidwell LP raised its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 111.9% in the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·6d ago
News Placeholder
Bellevue Group AG Boosts Stock Position in Edgewise Therapeutics, Inc. $EWTX
Bellevue Group AG raised its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 94.3% during the 2nd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·6d ago
News Placeholder
Schroder Investment Management Group Has $1.98 Million Holdings in Edgewise Therapeutics, Inc. $EWTX
Schroder Investment Management Group increased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 90.9% in the second quarter, according to the company in its most recent Form...
MarketBeat·12d ago
News Placeholder
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by Analysts
Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) has received a consensus rating of "Moderate Buy" from the twelve ratings firms that are presently covering the firm, MarketBeat.com...
MarketBeat·17d ago
News Placeholder
Wall Street Zen Upgrades Edgewise Therapeutics (NASDAQ:EWTX) to "Hold"
Wall Street Zen raised Edgewise Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·27d ago
News Placeholder
Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors
Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of...
PR Newswire·29d ago
News Placeholder
Edgewise Therapeutics (NASDAQ:EWTX) Given New $34.00 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted their target price on shares of Edgewise Therapeutics from $33.00 to $34.00 and gave the stock an "overweight" rating in a research note on Friday...
MarketBeat·1mo ago
News Placeholder
Jonathan Fox Purchases 10,700 Shares of Edgewise Therapeutics (NASDAQ:EWTX) Stock
Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) Director Jonathan Fox acquired 10,700 shares of Edgewise Therapeutics stock in a transaction on Tuesday, November 11th. The stock was...
MarketBeat·1mo ago
News Placeholder
Edgewise Therapeutics (NASDAQ:EWTX) Insider Sells $2,112,000.00 in Stock
Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) insider Alan Russell sold 100,000 shares of the company's stock in a transaction dated Wednesday, November 12th. The shares were sold at an...
MarketBeat·1mo ago
<
1
2
...
>

Latest EWTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.